Biocon Ltd logo

Biocon Ltd

NSE: BIOCON BSE: 532523

₹323.50

-6.80 (2.06%)

Tue, 03 Nov 2026, 07:22 am

mtf coin illustrationMTF 5xInvest in Biocon Ltd with 5x LeverageBuy with MTFpremium button ring illustration
Market Cap (in Cr)53174.33
PE Ratio96.22
Dividend0.15
Health TechnologyHealth Technology
Pharmaceuticals: MajorPharmaceuticals: Major
24.5K24.5K

Biocon Share Price Live Chart

1 Day

-6.80 (2.06%)

No Result Found

Summary

  • Market Cap (in Cr)

    57666.73

  • Net Profit (in Cr)

    368.8

  • P/B

    1.71

  • Sector P/E

    38.09

  • P/E

    151.62

  • EV/EBITDA

    20.84

  • Debt/Equity (Industry)

    0.18

  • Interest Cover (Industry)

    6.14

  • ROCE (Industry)

    4.95

  • RONW (Industry)

    3.78

  • ROE

    1.34

  • ROCE

    3.76

  • Debt/Equity

    0.61

  • EPS (TTM)

    4.48

  • Dividend Yield

    0.14

  • Book Value

    211.51

  • Interest Cover

    1.79

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersSEPT 2026JUN 2026MAR 2026DEC 2025SEPT 2025
Promoters44.6844.6844.9154.4554.45
FII8.648.147.527.396.61
DII29.3023.3824.0721.7122.10
Public17.3823.8023.4916.4516.83
Government00000

Read More

Technical Analysis

RSI

41.76

MACD

-8.14

50 DMA

374.35

200 DMA

390.44

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic459.85404.00377.90348.15322.05292.30236.45
Fibonacci404.00382.67369.48348.15326.82313.63292.30
Camarilla367.16362.04356.92348.15346.68341.56336.44

Pivots Level: Classic

R3

+111.70

459.85

R2

+55.85

404.00

R1

+29.75

377.90

348.15
348.15
Pivot Point
LTP: 343.95

S1

-26.10

322.05

S2

-55.85

292.30

S3

-111.70

236.45

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    345.77

  • 20-EMA

    350.17

  • 30-EMA

    357.04

  • 50-EMA

    369.03

  • 100-EMA

    383.25

  • 200-EMA

    386.51

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
22 Jun 2026agm
07 May 2026dividend₹0.50 Dividend /Share03 Jul 2026
07 May 2026board-meetingsAccounts, Final Dividend
12 Feb 2026board-meetingsQuarterly Results
06 Dec 2025egm
11 Nov 2025board-meetingsQuarterly Results
04 Jun 2025dividendFinal Dividend - Rs. - 0.504 Jul 2025
08 May 2025dividend₹0.50 Dividend /Share04 Jul 2025
08 May 2025agm
05 Jun 2024dividendFinal Dividend - Rs. - 0.505 Jul 2024

Read More

Peer Comparison

Biocon Ltd logo

Biocon Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Zydus Lifesciences Ltd logo

Zydus Lifesciences Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Laurus Labs Ltd logo

Laurus Labs Ltd

Read More

Biocon Ltd About

Biocon is engaged in the manufacture of biotechnology products and research services. The Company

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1978

Headquarters

CEO

Kiran Mazumdar Shaw

Employees

Contact

Website icon

Website

http://www.biocon.com

Email icon

Email

co.secretary@biocon.com

Phone icon

Phone

91-80-28082808

Location icon

Location

20th KM Hosur Road Hebbagodi, Electronic City P O, Bangalore, Karnataka, 560100

Read More

Biocon Ltd Company History

YearHistory
2021
  • Biocon launches Everolimus tablets in US.
  • Biocon enters out-licensing deal with Tabuk Pharmaceuticals.
  • Biocon Biologics’ interchangeable biosimilar Insulin Glargine preferred on Express Scripts’ US formulary.
  • Biocon enters Dow Jones Sustainability Emerging Markets Index.
  • Biocon partners with Tabuk Pharmaceuticals for speciality generics in Middle East.
2022
  • Biocon initiates clinical study of Itolizumab for Ulcerative Colitis in India.
  • Biocon Biologics completes acquisition of Viatris’ Global Biosimilars Business.
  • Biocon enters commercialization agreement with Zentiva in Europe.
  • Biocon ranks No. 8 in ‘Global Top Employers’ List by Science Magazine.
  • Biocon Foundation receives ‘Mahatma Award 2022 for Excellence in Social Good.
  • Biocon Sdn. Bhd. enters Malaysia Book of Records as largest integrated insulin facility.
2023
  • Biocon partners with Sandoz for Adalimumab BS distribution in Japan.
  • Biocon recognized as Asia IP Elite 2023; IPR Team named Team of the Year.
  • Biocon completes integration of Viatris’ Biosimilar Business in 31 European countries.
  • Biocon signs commercialization agreement with Juno Pharmaceuticals in Canada.
  • Biocon acquires manufacturing facility of Eywa Pharma Inc.
  • Biocon Biologics takes over commercialization of biosimilars from Viatris in 70+ emerging markets.
2024
  • Biocon ranked among Science Magazine’s Top 10 Global Employers.
  • Biocon Foundation honored with ‘Doing Good for Bharat Awards 2024’ in Healthcare Category for ‘eLAJ Smart Clinics’.
  • Biocon partners with Tabuk Pharmaceuticals to commercialize GLP-1 products in Middle East.
  • Biocon Foundation and IISc organize OCTF Conference on AI in Oral Cancer.
  • Biocon signs semi-exclusive distribution deal for generic Saxenda (Liraglutide) in Mexico.
2025
  • Biocon Biologics wins 'Data Privacy Program of the Year' at BW Tech World’s Tech Excellence Awards.
  • Biocon Biologics wins two awards at Asia Pacific Biopharma Excellence Awards (ABEA).
  • Biocon honored with Champion of CSR Award at ESG Impact Summit 2024.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
ACTIV PINE LLPblockSell127700038509 Sept 2026
ACTIV PINE LLPblockSell65000238509 Sept 2026
KOTAK MAHINDRA MATUAL FUNDblockBuy127700038509 Sept 2026
ADITYA BIRLA SUN LIFE MUTUAL FUNDblockBuy127700038509 Sept 2026
ACTIV PINE LLPblockSell127700038509 Sept 2026
ACTIV PINE LLPblockSell740316638509 Sept 2026
ICICI PRUDENTIAL MUTUAL FUNDblockBuy740316638509 Sept 2026
SBI MUTUAL FUNDblockBuy142399838509 Sept 2026
ACTIV PINE LLPblockSell142399838509 Sept 2026
ACTIV PINE LLPblockSell65000238509 Sept 2026

Read More

Biocon Ltd News

Biocon ranked No. 13 in Science magazine's 2026 employer survey

Biocon Limited secured the 13th spot among top global biopharma employers in Science magazine's 2026 survey, marking its 15th consecutive year on the list.

29 Oct 2026

companies

Biocon secures Yesintek market entry in 9 new countries

Biocon signs license with Janssen for Yesintek biosimilar in Australia, Brazil, China, and other key markets. This expands global reach for the Stelara competitor.

26 Oct 2026

companies

Biocon secures launch dates for Pebrilzo

Biocon Limited enters global patent settlement with Genentech, securing earliest licensed launch dates for its biosimilar Pebrilzo in EU, UK, and US.

14 Oct 2026

companies

Biocon shares flag large-trade signal on NSE

A large-trade signal flagged approximately 1,057,554 Biocon shares changing hands on NSE at ₹369.20, with a combined value of ₹39.04 crore.

06 Oct 2026

equity-markets

Biocon gets MHRA approval for Malaysia insulin unit

Biocon Limited secured MHRA approval for its new fill-finish unit for Semglee insulins in Malaysia, following earlier EMA clearance in July 2026.

25 Sept 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Biocon Ltd?

    As of 03/11/2026 at 12:52 PM, Biocon Ltd shares are trading at ₹323.50.

  • 2.What is the market cap. of Biocon Ltd?

    As of 03/11/2026, the market capitalization of Biocon Ltd is ₹53,174.33 crore.

  • 3.When was Biocon Ltd founded?

    Biocon Ltd was founded in 1978.

  • 4.What are the P/E and P/B ratios of Biocon Ltd?

    As of 03/11/2026, Biocon Ltd has a P/E ratio of 96.22 and a P/B ratio of 1.71.

  • 5.How can I buy shares of Biocon Ltd?

    You can buy shares of Biocon Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Biocon Ltd?

    As of September,2026, promoters hold 44.68% in Biocon Ltd, while FIIs, DIIs and public shareholders hold 8.64%, 29.30% and 17.38%, respectively.

  • 7.Does Biocon Ltd pay dividends?

    Yes, Biocon Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹0.50 Dividend /Share per share.

  • 8.What is the dividend yield of Biocon Ltd?

    As of 03 November, 2026, the dividend yield of Biocon Ltd stands at 0.15%.

  • 9.What are the latest financial results of Biocon Ltd?

    For the financial year ended March 2025, Biocon Ltd reported revenue of ₹15,211.00 crore and a net profit of ₹1,013.00 crore.

  • 10.What is the Stock symbol of Biocon Ltd?

    BIOCON is the stock symbol of Biocon Ltd.

  • 11.Who is the CEO of Biocon Ltd?

    The CEO of Biocon Ltd is Kiran Mazumdar Shaw.

pocketful logo lightpocketful logo dark
PricingBecome a Partner
search icon
/

No results for ''

Popular search

  • popular search iconSuzlon Energy Ltd
  • popular search iconIndian Railway Finance Corporation Ltd
  • popular search iconTata Motors Ltd
  • popular search iconTata Steel Ltd
  • popular search iconRail Vikas Nigam Ltd

Recent search

      Log In
      search icon

      No results for ‘’

        Popular search

        • popular search iconSuzlon Energy Ltd
        • popular search iconIndian Railway Finance Corporation Ltd
        • popular search iconTata Motors Ltd
        • popular search iconTata Steel Ltd
        • popular search iconRail Vikas Nigam Ltd
        • popular search iconReliance Industries Ltd
        pocketful logo lightpocketful logo dark
        • Pricing
        • Become a Partner
        Log In
        • home icon
        • arrow iconstocks
        • arrow iconbiocon ltd
        • Overview
        • Financials
        • Ratios
        • shareholding
        • Technical Analysis
        • Corporate Actions
        • Peer Comparison
        • About
        • Company History
        • Deals
        • News
        • FAQs

        Open Your Free Demat Account Now!

        Step into a world of zero fees and limitless opportunities!

        pocketful logo

        • Quick Links

          • Open Demat Account
          • Pocketful Web
          • Pocketful App
          • Pricing
          • Authorised Person
          • Pocketful Calculators
          • Compliance Links

        • Pages

          • Tools
          • Blogs
          • ETF Screener
          • IPO
          • ETF
          • Bonds
          • Index Heat Map

        • Products

          • Stocks
          • Commodity
          • Subscription
          • Free Stock Screener
          • Pocketful GPT
          • MTF
          • Mutual Funds

        • Company

          • About us
          • Contact us
          • Terms and Conditions
          • Policies & Procedures
          • Privacy Policy
          • Disclosure
          • Careers

        • Socials

          • Facebook iconFacebook
          • Twitter iconTwitter
          • Instagram iconInstagram
          • LinkedIn iconLinkedIn
          • Youtube iconYoutube

        2022-25 Pocketful. All rights reserved, Built with in India

        Version -5.76

        app image 1app image 2

        Stocks:

        AllABCDEFGHIJKLMNOPQRSTUVWXYZ

        Explore

        Calculators
        Popular Calculators
        Group Stocks
        Asset Management Companies
        Popular Stocks
        Indian Indices
        Sector Wise Stocks
        IPO
        Share Market
        Best MF Schemes
        Platforms
        Resources
        Gold Rates in Top Cities
        Silver Rates in Top Cities

        Others:

        NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

        Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800